Merck’s Clesrovimab Vote Reflects New ACIP Members’ Skepticism

 
• By Sue Sutter
Sleeping baby
Merck & Co's clesrovimab is recommended for prevention of RSV in infants. (Shutterstock)

More from US Advisory Committees

More from United States